(Q87806275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

main subject

hepatocellular carcinoma

1 reference

Kai Wei

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Meng Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Wei Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Han Mu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Tian-Qiang Song

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

4 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

969

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

17 March 2020

cites work

1 reference

12 December 2020

Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.

1 reference

12 December 2020

Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

1 reference

12 December 2020

Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).

1 reference

12 December 2020

Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

1 reference

12 December 2020

Hepatocellular carcinoma in Central Europe: prognostic features and survival

1 reference

12 December 2020

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

12 December 2020

Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms

1 reference

12 December 2020

Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer

1 reference

12 December 2020

Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation

1 reference

12 December 2020

Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma

1 reference

12 December 2020

Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy

1 reference

12 December 2020

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.

1 reference

12 December 2020

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Novel advancements in the management of hepatocellular carcinoma in 2008.

1 reference

12 December 2020

The neutrophil as a cellular source of chemokines

1 reference

12 December 2020

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

1 reference

12 December 2020

Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer

1 reference

12 December 2020

Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma

1 reference

12 December 2020

Treatment options in hepatocellular carcinoma today.

1 reference

12 December 2020

Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer.

1 reference

12 December 2020

Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

1 reference

12 December 2020

Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

1 reference

12 December 2020

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

1 reference

12 December 2020

Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer

1 reference

12 December 2020

Increased Expression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization

1 reference

12 December 2020

Angiogenesis in cancer and other diseases

1 reference

12 December 2020

Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

1 reference

12 December 2020

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

1 reference

12 December 2020

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

1 reference

12 December 2020

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

1 reference

12 December 2020

Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor

1 reference

12 December 2020

Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization

1 reference

12 December 2020

Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?

1 reference

12 December 2020

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

12 December 2020

Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.

1 reference

12 December 2020

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

1 reference

12 December 2020

The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma

1 reference

12 December 2020

An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma

1 reference

12 December 2020

Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model

1 reference

12 December 2020

Chronic inflammation and hepatocellular carcinoma

1 reference

12 December 2020

The blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib

1 reference

12 December 2020

Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer.

1 reference

12 December 2020

10.1007/S12032-014-0969-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24793745%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference